Synonyms 2型血管性血友病, Hereditary von Willebrand disease type 2, Hereditary von Willebrand disease type 2 (disorder) + [75] |
Introduction A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction. |
Target |
Mechanism F10 stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date22 Feb 2023 |
Target |
Mechanism vWF inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date30 Aug 2024 |
Sponsor / Collaborator Hemab ApS [+1] |
Start Date03 May 2021 |
Sponsor / Collaborator |
Start Date16 Dec 2020 |
Sponsor / Collaborator |